463 related articles for article (PubMed ID: 20730088)
1. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
Tempera I; Wiedmer A; Dheekollu J; Lieberman PM
PLoS Pathog; 2010 Aug; 6(8):e1001048. PubMed ID: 20730088
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of latent Epstein-Barr virus promoters.
Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
[TBL] [Abstract][Full Text] [Related]
3. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.
Lupey-Green LN; Caruso LB; Madzo J; Martin KA; Tan Y; Hulse M; Tempera I
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976663
[TBL] [Abstract][Full Text] [Related]
4. EBV latency types adopt alternative chromatin conformations.
Tempera I; Klichinsky M; Lieberman PM
PLoS Pathog; 2011 Jul; 7(7):e1002180. PubMed ID: 21829357
[TBL] [Abstract][Full Text] [Related]
5. Binding of CCCTC-binding factor in vivo to the region located between Rep* and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity.
Salamon D; Banati F; Koroknai A; Ravasz M; Szenthe K; Bathori Z; Bakos A; Niller HH; Wolf H; Minarovits J
J Gen Virol; 2009 May; 90(Pt 5):1183-1189. PubMed ID: 19264589
[TBL] [Abstract][Full Text] [Related]
6. Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.
Hughes DJ; Marendy EM; Dickerson CA; Yetming KD; Sample CE; Sample JT
J Virol; 2012 Jan; 86(2):1034-45. PubMed ID: 22072770
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of Epstein-Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites on the Viral Genome.
Dunn LEM; Lu F; Su C; Lieberman PM; Baines JD
J Virol; 2023 Feb; 97(2):e0189422. PubMed ID: 36744959
[TBL] [Abstract][Full Text] [Related]
8. Chromatin profiling of Epstein-Barr virus latency control region.
Day L; Chau CM; Nebozhyn M; Rennekamp AJ; Showe M; Lieberman PM
J Virol; 2007 Jun; 81(12):6389-401. PubMed ID: 17409162
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency.
Schaefer BC; Paulson E; Strominger JL; Speck SH
Mol Cell Biol; 1997 Feb; 17(2):873-86. PubMed ID: 9001242
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells.
Paulson EJ; Fingeroth JD; Yates JL; Speck SH
Virology; 2002 Jul; 299(1):109-21. PubMed ID: 12167346
[TBL] [Abstract][Full Text] [Related]
11. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.
Chau CM; Zhang XY; McMahon SB; Lieberman PM
J Virol; 2006 Jun; 80(12):5723-32. PubMed ID: 16731911
[TBL] [Abstract][Full Text] [Related]
14. CpG-methylation regulates a class of Epstein-Barr virus promoters.
Bergbauer M; Kalla M; Schmeinck A; Göbel C; Rothbauer U; Eck S; Benet-Pagès A; Strom TM; Hammerschmidt W
PLoS Pathog; 2010 Sep; 6(9):e1001114. PubMed ID: 20886097
[TBL] [Abstract][Full Text] [Related]
15. Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.
Schaefer BC; Strominger JL; Speck SH
Mol Cell Biol; 1997 Jan; 17(1):364-77. PubMed ID: 8972217
[TBL] [Abstract][Full Text] [Related]
16. BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
Woellmer A; Arteaga-Salas JM; Hammerschmidt W
PLoS Pathog; 2012 Sep; 8(9):e1002902. PubMed ID: 22969425
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site.
Chen HS; Martin KA; Lu F; Lupey LN; Mueller JM; Lieberman PM; Tempera I
J Virol; 2014 Feb; 88(3):1703-13. PubMed ID: 24257606
[TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.
Tao Q; Robertson KD; Manns A; Hildesheim A; Ambinder RF
J Virol; 1998 Sep; 72(9):7075-83. PubMed ID: 9696800
[TBL] [Abstract][Full Text] [Related]
19. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection.
Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K
J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278
[TBL] [Abstract][Full Text] [Related]
20. Epigenotypes of latent herpesvirus genomes.
Minarovits J
Curr Top Microbiol Immunol; 2006; 310():61-80. PubMed ID: 16909907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]